Elsevier launches case report journal

Elsevier launched the International Journal of Surgery Case Reports (IJSCR), a new online journal dedicated exclusively to case reports.

The journal will serve as the companion to the International Journal of Surgery, and will be published eight times a year, in concert with its parent title. Submissions to the IJSC are peer-reviewed, although authors will have to pay almost $400 to publish their submissions, once accepted for publication.

Tom Reller, an Elsevier spokesperson, said the company has used the “author pays” model before, and IJSC has already received approximately 50 submissions for review. A few IJSC case reports have already been published in the company's Articles in Press category and included in the ScienceDirect online platform, and the first issue of the journal will publish “very shortly,” according to Reller. IJSC will be distributed as an online-only title.

Drug and device advertising is not currently present in the journal, although Reller said the implementation of ads “is certainly a possibility going forward.” Reller said the number of case reports per issue has yet to be determined, but that Elsevier expects the number to increase steadily over time.

“While infrequently cited for research purposes, case reports are popular and represent some of the oldest levels of evidence,” said David Rosin, editor-in-chief, and Riaz Agha, managing director and executive editor, in a joint statement.

Case reports include stories, anecdotes and patient-based learnings, and Elsevier hopes to raise their academic value by building a database of the reports, which “could be mined for interesting trends/patterns, disease modeling and for the purposes of surveillance, specially of rare diseases,” the statement said. Upon acceptance, case reports will also be posted on PubMed Central for accessibility across Elsevier's websites.
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.